H. Muller-Hermelink

发表

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

L. Staudt, R. Davis, A. Rosenwald, 2008, Proceedings of the National Academy of Sciences.

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

L. Staudt, A. Rosenwald, J. Powell, 2002, The New England journal of medicine.

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

L. Staudt, A. Rosenwald, Xin Yu, 2003, The Journal of experimental medicine.

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

L. Staudt, A. Rosenwald, J. Powell, 2004, The New England journal of medicine.

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.

L. Staudt, A. Rosenwald, W. Chan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

L. Staudt, A. Rosenwald, J. Powell, 2005, Blood.

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

L. Staudt, A. Rosenwald, J. Powell, 2003, Cancer cell.

Stromal gene signatures in large-B-cell lymphomas.

L. Staudt, W. C. Chan, A. Rosenwald, 2008, The New England journal of medicine.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.

Dirk Hasenclever, Peter Koch, Markus Sieber, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Jan Delabie, Wenming Xiao, Weihong Xu, 2010, Nature.

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

Jan Delabie, Randy D Gascoyne, Weihong Xu, 2008, Science.

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Adrian Wiestner, Hui Liu, Kazutaka Nakayama, 2007, Blood.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Steven J. M. Jones, Christian Steidl, Javeed Iqbal, 2010, The New England journal of medicine.

Cooperative epigenetic modulation by cancer amplicon genes.

Christian Steidl, Peter Möller, Jan Delabie, 2010, Cancer cell.

Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States

H. Muller-Hermelink, S. Swerdlow, Sindy Hu, 2008, Modern Pathology.

Human monoclonal antibodies from stomach carcinoma patients react with helicobacter pylori and stimulate stomach cancer cells in vitro

H. Muller-Hermelink, H. Vollmers, H. Konrad Müller‐Hermelink, 1994, Cancer.

Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles that Influence Tumor Biology and Improve Gene Expression-Based Survival Prediction for the Lymphoma/Leukemia Molecular Profiling Project

Rita, Armitage, L. Staudt, 2005 .

The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.

H. Muller-Hermelink, E. Jaffe, M. Raffeld, 2003, Blood.

The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity

H. Muller-Hermelink, E. Jaffe, M. Raffeld, 2002 .

Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative disease.

A. Marx, H. Muller-Hermelink, H. Einsele, 2008, Annals of Internal Medicine.

Oncogenically active MYD88 mutations in human lymphoma

Joseph M. Connors, Randy D. Gascoyne, Roland Schmitz, 2011, Nature.

Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation.

H. Muller-Hermelink, S. Gattenlöhner, E. Brocker, 2008, The New England journal of medicine.

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2007, The Journal of experimental medicine.

Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma

Jan Delabie, Randy D Gascoyne, Andreas Rosenwald, 2007, Genes, chromosomes & cancer.

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

L. Staudt, A. Rosenwald, W. Chan, 2004, Blood.

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation

A. Rosenwald, G. Ott, H. Müller-Hermelink, 2006, Leukemia.

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

L. Staudt, A. Rosenwald, W. Chan, 2005, Blood.

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.

L. Staudt, A. Rosenwald, W. Chan, 2006, Blood.

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

B. Nathwani, D. Weisenburger, J. Armitage, 2012, Leukemia & lymphoma.

lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell

L. Staudt, A. Rosenwald, T. Greiner, 2013 .

Genetic Lesions and Their Role in Classification and Progression 19

G. Ott, H. Muller-Hermelink, J. Bartek, 1996 .

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

G Flandrin, J Diebold, C. Bloomfield, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States

H. Muller-Hermelink, S. Swerdlow, Sindy Hu, 2008, Modern Pathology.

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Meland, L. Staudt, A. Rosenwald, 2002, The New England journal of medicine.

Primary Low‐Grade Hepatic B‐Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue (MALT)‐Type

H. Muller-Hermelink, P. Banks, P. Isaacson, 1995, The American journal of surgical pathology.

A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version.

R. Warnke, N. Harris, H. Muller-Hermelink, 1995, American journal of clinical pathology.

The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

C. Bloomfield, J. Diebold, N. Harris, 2000, Modern Pathology.

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

H. Muller-Hermelink, Jacques Diebold, Georges Flandrin, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

L. Staudt, A. Rosenwald, J. Powell, 2007 .

Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.

B. Nathwani, D. Weisenburger, J. Armitage, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.